// App-Quantinova.ai

1188 : Safety and Efficacy of Glecaprevir/Pibrent‐ asvir in Patients Aged 65 Years or Older With Chronic Hepatitis C: A Pooled Analysis of Phase 2 and 3 Clinical Trials

Researchers

Presenter

  • Graham R. Foster

Principal Investigators

  • Sarah Kopecky-Bromberg

  • Yang Lei

  • Federico J. Mensa

Medical Centers

  • Queen Mary University of London, London, United Kingdom

  • AbbVie, Inc., North Chicago, IL

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

Biomarkers

  • Sustained virological response

Drug/Treatment

  • Glecaprevir

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved